Investor Presentaiton slide image

Investor Presentaiton

Continuing to advance our oncology strategy Immuno-oncology Boost anti-tumor immune responses Precision Molecular Targeting Impact pathways that can drive cancer growth Tissue Targeting Increase cancer cell sensitivity with ADCs and immune-engagers MERCK 20
View entire presentation